Global Recombinant Vaccines Market, By Product Type (Subunit Recombinant Vaccines, Attenuated Recombinant Vaccines, Vector Recombinant Vaccines), Disease Type (Infectious Disease, Cancer, Allergy), End User (Recombinant Human Vaccines, Animal Recombinant

Global Recombinant Vaccines Market, By Product Type (Subunit Recombinant Vaccines, Attenuated Recombinant Vaccines, Vector Recombinant Vaccines), Disease Type (Infectious Disease, Cancer, Allergy), End User (Recombinant Human Vaccines, Animal Recombinant Vaccines), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast, 2022 - 2028

Report Description
Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease. These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue. Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms. There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population. According to Global Agriculture report, there were around 315 million tons of meat produced worldwide in 2014 and expected to increase to 318.8 million tons in 2015.
Market Dynamics
The recent past has witnessed a steady rise in incidence of zoonotic and infectious diseases in humans and animals as well, which lead to the increased research & developments for the innovation of new and effective recombinant vaccines for the prevention of diseases. Government has also taken an initiative to increase awareness regarding vaccination to prevent diseases in community. Manufacturing companies have also started some beneficial programs to provide vaccination free of cost to poor people, which creates a highly conducive environment for growth of the recombinant vaccines market in near future.
National Immunization Program by Queensland Government in Australia and Indradhanush vaccination program in India works to provide vaccination among children throughout the nation. Various organizations such as World Health Organization, World Bank, and United Nations Children’s Funds has also taken and initiative to increase vaccination.
Market Taxonomy
The report segments the global recombinant vaccines market on basis of product type, end user, disease type and geography. On the basis of product type, the market is categorized into subunit recombinant vaccines, attenuated vaccines, and vector recombinant vaccines. Among these, the vector recombinant vaccines segment dominates the recombinant vaccines market throughout the forecast period. On the basis of disease type, the market is categorized into infectious disease, cancer, allergy, and others. On the basis of end user, the market is categorized into recombinant human vaccines and animal recombinant vaccines. On the basis of geography, the market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among all regions, North America contributes major market share supported by increased awareness among people and increase in infectious and viral diseases.
Key features of the study:
This report provides in-depth analysis of the recombinant vaccines market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline products, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global Recombinant Vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics
The global recombinant vaccines market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, medical devices companies, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the recombinant vaccines market
Detailed Segmentation
Global Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Global Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Global Recombinant Vaccines Market, End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Global Recombinant Vaccines Market, By Geography:
North America
North America Recombinant Vaccines Market, By Product Type:
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
North America Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
North America Recombinant Vaccines Market, End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
North America Recombinant Vaccines Market, By Country:
U.S.
U.S. Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
U.S. Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
U.S. Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Canada
Canada Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Canada Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Canada Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Europe
Europe Recombinant Vaccines Market, By Product Type:
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Europe Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Europe Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Europe Recombinant Vaccines Market, By Country:
Germany
Germany Recombinant Vaccines Market, Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Germany Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Germany Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
U.K.
U.K. Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
U.K. Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
U.K. Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
France
France Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
France Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
France Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Italy
Italy Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Italy Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Italy Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Spain
Spain Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Spain Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Spain Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Russia
Russia Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Russia Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Russia Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Rest of Europe
Rest of Europe Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Rest Of Europe Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Rest Of Europe Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Asia Pacific
Asia Pacific Recombinant Vaccines Market, By Product Type:
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Asia Pacific Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Asia Pacific Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Asia Pacific Recombinant Vaccines Market, By Country:
China
China Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
China Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
China Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
India
India Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
India Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
India Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Japan
Japan Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Japan Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Japan Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Australia
Australia Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Australia Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Australia Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture vaccines
South Korea
South Korea Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
South Korea Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
South Korea Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
ASEAN
ASEAN Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
ASEAN Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
ASEAN Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Rest of Asia Pacific
Rest of Asia Pacific Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Rest of Asia Pacific Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Rest of Asia Pacific Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Latin America
Latin America Recombinant Vaccines Market, By Product Type:
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Latin America Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Latin America Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Latin America Recombinant Vaccines Market, By Country:
Brazil
Brazil Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Brazil Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Brazil Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Mexico
Mexico Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Mexico Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Mexico Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Argentina
Argentina Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Argentina Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Argentina Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Rest of Latin America
Rest of Latin America Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Rest of Latin America Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Rest of Latin America Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Middle East
Middle East Recombinant Vaccines Market, By Product Type:
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Middle East Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Middle East Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Middle East Recombinant Vaccines Market, By Country:
GCC
GCC Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
GCC Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
GCC Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Israel
Israel Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Israel Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Israel Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Rest of Middle-East
Rest of Middle-East Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Rest of Middle-East Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Rest of Middle-East Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Africa
Africa Recombinant Vaccines Market, By Product Type:
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Africa Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Africa Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines
Africa Recombinant Vaccines Market, By Country:
North Africa
North Africa Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
North Africa Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
North Africa Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Central Africa
Central Africa Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Central Africa Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Central Africa Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
South Africa
South Africa Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
South Africa Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
South Africa Recombinant Vaccines Market, By End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Company Profiles
Merck & Co., Inc.,*
Company Overview
Product Portfolio
Market Presence
Financial Overview
Key Developments
Strategies
Green Cross Corporation
Pfizer Inc.
Bayer AG
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc.
Novartis AG
Bharat Biotech

“*” marked represents similar segmentation in other categories in the respective section.